FDA Should Publish QT Prolongation Database, Industry Reps Say
Executive Summary
Industry wants FDA to make available a database of results from QT prolongation studies
You may also be interested in...
ECG Warehouse May Be Model For Critical Path FDA/Industry Partnerships
FDA's "ECG warehouse" could be a prototype for cardiovascular safety collaborations between FDA and industry under the Critical Path initiative, Center for Drug Evaluation & Research Deputy Director Douglas Throckmorton said Oct. 11
ECG Warehouse May Be Model For Critical Path FDA/Industry Partnerships
FDA's "ECG warehouse" could be a prototype for cardiovascular safety collaborations between FDA and industry under the Critical Path initiative, Center for Drug Evaluation & Research Deputy Director Douglas Throckmorton said Oct. 11
QT Guidance Reducing Number Of Drugs Leaving Early Development, Firms Say
Stricter guidelines on QT prolongation are forcing manufacturers to drop compounds earlier in the development process, participants said during an FDA/Duke Cardiac Safety and Critical Path Initiative Think Tank meeting Oct. 11